<DOC>
	<DOC>NCT02670863</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and efficacy of the experimental formula supplemented with a prebiotic vs the control formula.</brief_summary>
	<brief_title>Safety and Efficacy Study</brief_title>
	<detailed_description>Randomized, double-blind, controlled interventional clinical trial design. The purpose of this study is to evaluate the safety and efficacy of a new term infant formula supplemented with a prebiotic vs a standard infant formula fed for 150 days to healthy, term infants.</detailed_description>
	<criteria>Written Informed Consent Infants whose parent(s)/LAR have reached the legal age of majority in the Philippines Infants whose parent(s)/LAR are willing and able to comply with study requirements Infants whose parent(s)/LAR are able to be contacted by telephone throughout the study Healthy term, singleton infant at birth Between 21 to 26 days postnatal age at enrollment visit Weightforlength and head circumferenceforage zscores &gt;/= 3 and &lt;/= +3 according to WHO Child Growth Standards Infants of parent(s)/LAR who have previously made the decision to formula feed their infant at the time of enrollment Infants with conditions requiring infant feedings other than those specified in the protocol Infants receiving complementary foods or liquids Infants who have a medical condition or history that could increase the risk associated with study participation or interfere with the interpretation of study results Infants who are presently receiving or have received medications that could interfere with the interpretation of study results Infants or infants whose parents/LAR cannot be expected to comply with the protocol or with study procedures</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>26 Days</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>